World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
45
Citations
7017
World Ranking
4715
National Ranking
205

Francesco Caso publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Francesco Caso sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 213 publications — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Francesco Caso D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Francesco Caso sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 45 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Francesco Caso is affiliated with the University of Naples Federico II in Italy and has a significant research presence in the field of medicine, with particular focus on rheumatology, immunology, and hematology. Their work spans several core topics including spondyloarthritis studies and treatments, psoriasis treatment and pathogenesis, autoimmune and inflammatory disorders research, and rheumatoid arthritis research and therapies. Additional areas of study involve inflammasome and immune disorders as well as systemic lupus erythematosus and COVID-19 clinical research studies.

Their publication record includes multiple papers across prominent journals and reviews. Selected recent works include:

  • Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects? (2020) in Autoimmunity Reviews
  • Interleukin-17A (IL-17A): A silent amplifier of COVID-19 (2021) in Biomedicine & Pharmacotherapy

They have contributed to the literature in well-regarded venues, with frequent publications in:

  • Annals of the Rheumatic Diseases
  • Clinical and Experimental Rheumatology
  • Autoimmunity Reviews
  • Clinical Rheumatology
  • Lara D. Veeken

Collaboration forms a notable part of their work, sharing authorship with several frequent co-authors including:

  • Luisa Costa
  • Raffaele Scarpa
  • Roberto Giacomelli
  • Marco Tasso
  • Piero Ruscitti

Their research contributions have accrued citations in various key papers, reflecting ongoing interest in their studies on autoimmune mechanisms related to COVID-19 and rheumatic diseases. Their multidisciplinary approach intersects molecular biology and dermatology, further broadening the scope of their investigations within the clinical and experimental study of immune-mediated conditions.

Best Publications

  • Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?

    Francesco Caso;Luisa Costa;Piero Ruscitti;Luca Navarini

  • Overlap connective tissue disease syndromes

    Luca Iaccarino;Mariele Gatto;Silvano Bettio;Francesco Caso

  • Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis.

    Roberto Giacomelli;Antonella Afeltra;Alessia Alunno;Elena Bartoloni-Bocci

  • Blau syndrome, clinical and genetic aspects

    Paolo Sfriso;Francesco Caso;Sofia Tognon;Paola Galozzi

  • Anakinra treatment in drug-resistant Behcet's disease: a case series.

    Luca Cantarini;Antonio Vitale;Perla Scalini;Charles A. Dinarello;Charles A. Dinarello

  • Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's disease.

    Francesco Caso;Paola Galozzi;Luisa Costa;Paolo Sfriso

  • Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study.

    Luisa Costa;Francesco Caso;Lanfranco D’Elia;Mariangela Atteno

  • Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients

    Luisa Costa;Francesco Caso;Mariangela Atteno;Antonio Del Puente

  • Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues.

    Francesco Caso;Donato Rigante;Antonio Vitale;Orso Maria Lucherini

  • Diagnosis and classification of relapsing polychondritis

    Luca Cantarini;Antonio Vitale;Maria Giuseppina Brizi;Francesco Caso

  • Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease.

    Luca Cantarini;Giuseppe Lopalco;Francesco Caso;Luisa Costa

  • Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs

    Mariangela Atteno;Rosario Peluso;Luisa Costa;Stefania Padula

  • Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients

    Paolo Sfriso;Roberta Priori;Guido Valesini;Silvia Rossi

  • The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-up.

    Luca Cantarini;Donato Rigante;Giampaolo Merlini;Antonio Vitale

  • Biological treatments: new weapons in the management of monogenic autoinflammatory disorders.

    Antonio Vitale;Donato Rigante;Orso Maria Lucherini;Francesco Caso

  • Psoriatic arthritis and psoriasis: differential diagnosis

    Maddalena Napolitano;Francesco Caso;Raffaele Scarpa;Matteo Megna

  • Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis.

    Francesco Caso;Luisa Costa;Donato Rigante;Antonio Vitale

  • Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behçet's Disease: A Case Series

    Antonio Vitale;Donato Rigante;Francesco Caso;Maria Giuseppina Brizi

  • Biological Treatments in Behçet’s Disease: Beyond Anti-TNF Therapy

    Francesco Caso;Luisa Costa;Donato Rigante;Orso Maria Lucherini

  • Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study

    Luisa Costa;Francesco Caso;Francesco Caso;Roberta Ramonda;Antonio Del Puente

Frequent Co-Authors

Leonardo Punzi
Leonardo Punzi University of Padua
Maria Sole Chimenti
Maria Sole Chimenti University of Rome Tor Vergata
Roberto Perricone
Roberto Perricone University of Rome Tor Vergata
Roberto Giacomelli
Roberto Giacomelli Campus Bio Medico University Hospital
Antonella Afeltra
Antonella Afeltra Università Campus Bio-Medico di Roma
Andrea Doria
Andrea Doria University of Padua
Paola Cipriani
Paola Cipriani University of L'Aquila
Carlo Salvarani
Carlo Salvarani University of Modena and Reggio Emilia
Fabiola Atzeni
Fabiola Atzeni University of Messina
Rolando Cimaz
Rolando Cimaz University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can broaden career options in healthcare and research. Accelerated pathways, such as accelerated np programs, offer a fast track for advanced nursing roles that often intersect with immunological care and treatment.

Individuals without a nursing background can also transition smoothly into healthcare through online absn programs for non nurses. These programs provide essential clinical knowledge that complements immunology research and patient care roles.

For those seeking foundational nursing credentials quickly, accelerated nursing programs offer accessible entry points. These programs help prepare students for diverse roles where immunology expertise is valuable.

Additionally, practical nursing careers can be launched through the best easiest lpn programs to get into, providing hands-on experience fundamental to many immunology-related healthcare settings.

Best Scientists Citing Francesco Caso

Trending Scientists